Gülfe A, Geborek P, Saxne T
Department of Rheumatology, Lund University Hospital, SE-221 85 Lund, Sweden.
Ann Rheum Dis. 2005 Aug;64(8):1186-9. doi: 10.1136/ard.2004.027649. Epub 2005 Mar 10.
To compare the performance of the American College of Rheumatology (ACR), European League Against Rheumatism (EULAR), and simple disease activity index (SDAI) response criteria for rheumatoid arthritis at the individual level in an observational cohort.
184 outpatients were followed using a structured protocol. For each patient, the responses according to ACR 20% and 50%, EULAR moderate and good, and SDAI minor and major responses were calculated. For comparison, improvements in health assessment questionnaire (HAQ) score of 0.22 and 0.5 were calculated. The numbers of individuals fulfilling the criteria at each level were compared, and the numbers fulfilling any two sets of response criteria calculated. The EULAR "moderate" and "good" responses were grouped together as "overall," and SDAI "minor" and "major" were merged into SDAI "overall".
All 94 ACR 20 responders were found in the EULAR and SDAI "overall" response groups, and 118 of 124 SDAI "overall" responders were found in the EULAR "overall" group. In contrast, of 53 ACR 50 responders, only 34 were found in the EULAR "good" or SDAI "major" group. Among the 56 patients in the EULAR "good" response group, only 26 met the SDAI "major" response. Improvement in HAQ score performed similarly to the other response criteria sets at the group levels.
For individual patients, agreement is good at the level of ACR 20 response, when EULAR overall, SDAI overall, or HAQ 0.22 criteria are applied. Agreement between ACR 50, EULAR good, SDAI major, and HAQ 0.5 response is poor. This should be considered when response criteria are used for clinical decisions.
在一个观察性队列中,在个体层面比较美国风湿病学会(ACR)、欧洲抗风湿病联盟(EULAR)以及类风湿关节炎简单疾病活动指数(SDAI)反应标准的表现。
采用结构化方案对184名门诊患者进行随访。对于每位患者,计算根据ACR 20%和50%、EULAR中度和良好、以及SDAI轻度和主要反应的应答情况。为作比较,计算健康评估问卷(HAQ)评分改善0.22和0.5的情况。比较达到各水平标准的个体数量,并计算达到任意两组反应标准的个体数量。将EULAR“中度”和“良好”反应合并为“总体”,SDAI“轻度”和“主要”合并为SDAI“总体”。
在EULAR和SDAI“总体”反应组中发现了所有94名ACR 20应答者,在EULAR“总体”组中发现了124名SDAI“总体”应答者中的118名。相比之下,在53名ACR 50应答者中,只有34名在EULAR“良好”或SDAI“主要”组中。在EULAR“良好”反应组的56名患者中,只有26名符合SDAI“主要”反应。在组水平上,HAQ评分的改善与其他反应标准集表现相似。
对于个体患者,应用EULAR总体、SDAI总体或HAQ 0.22标准时,在ACR 20反应水平上一致性良好。ACR 50、EULAR良好、SDAI主要和HAQ 0.5反应之间的一致性较差。在将反应标准用于临床决策时应考虑这一点。